AtriCure ATRC Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $826K+20.9% | $683K+527% | $109K-69.7% | $360K+185% | -$424K-30.1% | ||
| —— | —— | -$28.77M+20.9% | -$36.36M+4.8% | -$38.18M+14.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is AtriCure's revenue?
- AtriCure (ATRC) generated $552.2M in revenue over the trailing twelve months, up 15.0% year over year.
- Is AtriCure profitable?
- AtriCure is not currently profitable: it reported a net loss of $13.1M over the trailing twelve months, a -5.6% net margin.
- What are AtriCure's profit margins?
- Gross margin is 75.6% and operating margin is -5.1%, with a -5.6% net margin.
- What is AtriCure's earnings per share?
- AtriCure's diluted EPS over the trailing twelve months is $-0.28.
- Where does AtriCure's income statement data come from?
- Every line is extracted from AtriCure's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
